汤小虎
About 汤小虎
汤小虎 is the Chief Scientist overseeing active pharmaceutical ingredient synthesis regulation in Asia at Bristol-Myers Squibb, with over 8 years of experience in the field.
Current Position at Bristol-Myers Squibb
汤小虎 currently holds the position of Chief Scientist, overseeing the regulatory affairs of active pharmaceutical ingredient (API) synthesis in the Asian region at Bristol-Myers Squibb. He has been with the company since June 2015 and continues to play a crucial role in ensuring compliance and efficiency in the synthesis of essential drug components.
Education and Academic Background
汤小虎 has an extensive educational background in chemistry. He earned his Ph.D. in Organic Chemistry from the Shanghai Institute of Organic Chemistry, part of the Chinese Academy of Sciences, in 2003. Prior to this, he completed a Bachelor's degree in Environmental Chemistry from Nanjing University in 1996. His academic pursuits have provided a strong foundation for his career in pharmaceutical sciences.
Experience in Pharmaceutical Regulatory Affairs
With over 8 years of experience in regulatory oversight for active pharmaceutical ingredient synthesis, 汤小虎 has established himself as a knowledgeable and reliable figure in the Asian pharmaceutical regulatory landscape. His role includes ensuring that the synthesis processes meet stringent international standards, optimizing production practices, and maintaining compliance with regulatory requirements.
Academic Achievements
汤小虎's academic journey reflects significant achievements. He spent five years at the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, where he focused on organic chemistry and received his Ph.D. in 2003. Additionally, his earlier studies at Nanjing University, where he achieved a Bachelor's degree in Environmental Chemistry, laid the groundwork for his later specialization in organic chemistry and pharmaceutical sciences.